Capital expenditure increased 150.7%
Capital expenditure changed +150.7% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +150.7% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Free-cash-flow proxy changed -124.9% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
Net income changed +83.2% from the comparable as-filed period.
Operating cash flow changed -123.4% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
Revenue changed +11.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +60.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash & equivalents changed -8.1% from the comparable as-filed period.
Operating margin changed -169 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +11 basis points from the comparable as-filed period.
Operating income changed -1.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.